Rita Golfieri, Josè Ignacio Bilbao, Livio Carpanese, Roberto Cianni, Daniele Gasparini, Samer Ezziddin, Philipp Marius Paprottka, Francesco Fiore, Alberta Cappelli, Macarena Rodriguez, Giuseppe Maria Ettorre, Adelchi Saltarelli, Onelio Geatti, Hojjat Ahmadzadehfar, Alexander R Haug, Francesco Izzo, Emanuela Giampalma, Bruno Sangro, Giuseppe Pizzi, Ermanno Notarianni, Alessandro Vit, Kai Wilhelm, Tobias F Jakobs, Secondo Lastoria
BACKGROUND & AIMS: The European Network on Radioembolization with Yttrium-90 resin microspheres study group (ENRY) conducted a retrospective study to evaluate the outcomes among elderly (≥ 70 years) and younger patients (<70 years) with unresectable hepatocellular carcinoma (HCC) who received radioembolization at 8 European centers. METHODS: Patients with confirmed diagnosis of unresectable HCC who either progressed following resection or locoregional treatment and/or who were considered poor candidates for chemoembolization were evaluated by a multidisciplinary team for radioembolization with (90)Y-resin microspheres (SIR-Spheres; Sirtex Medical)...
October 2013: Journal of Hepatology